We have previoulsy shown that patients with active Tuberculosis develop a wide array of autoantibodies including rheumatoid factor, anti-CCP, Antinuclear facyor and anti Sm antibodies. The purpose of this study is to evaluate whether the level of autoantibodies decrease after treatment aganist tuberculosis.
Study Type
OBSERVATIONAL
Enrollment
50
Tel Aviv Medical Center
Tel Aviv, Tel Aviv, Israel
Follow up after levels of autoantibodies
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.